News Home

Can Cabaletta Bio Inc (CABA) Stock Rise to the Top of Healthcare Sector Tuesday?

Tuesday, September 26, 2023 11:56 AM | InvestorsObserver Analysts

Mentioned in this article

Can Cabaletta Bio Inc (CABA) Stock Rise to the Top of Healthcare Sector Tuesday?

The 85 rating InvestorsObserver gives to Cabaletta Bio Inc (CABA) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 99 percent of stocks in the Healthcare sector, CABA’s 85 overall rating means the stock scores better than 85 of all stocks.

Overall Score - 85
CABA has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on CABA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 85 means the stock is more attractive than 85 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cabaletta Bio Inc Stock Today?

Cabaletta Bio Inc (CABA) stock is higher by 3.19% while the S&P 500 is down -1.18% as of 11:44 AM on Tuesday, Sep 26. CABA has gained $0.49 from the previous closing price of $15.37 on volume of 217,067 shares. Over the past year the S&P 500 has risen 17.27% while CABA has gained 2417.46%. CABA lost -$1.73 per share the over the last 12 months. Click Here to get the full Stock Report for Cabaletta Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App